⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for demcizumab

Every month we try and update this database with for demcizumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerNCT01189929
Pancreatic Canc...
Demcizumab
Abraxane®
Gemcitabine
21 Years - Mereo BioPharma
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung CancerNCT02259582
Nonsquamous Non...
Pemetrexed
Carboplatin
demcizumab
21 Years - Mereo BioPharma
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant OvarianNCT01952249
Primary Periton...
Demcizumab
Taxol
21 Years - 90 YearsMereo BioPharma
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung CancerNCT01189968
Non Small Cell ...
Demcizumab
21 Years - Mereo BioPharma
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerNCT01189929
Pancreatic Canc...
Demcizumab
Abraxane®
Gemcitabine
21 Years - Mereo BioPharma
Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaNCT02289898
Pancreatic Canc...
Demcizumab
Abraxane®
gemcitabine
Placebo
21 Years - Mereo BioPharma
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant OvarianNCT01952249
Primary Periton...
Demcizumab
Taxol
21 Years - 90 YearsMereo BioPharma
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: